Ioanna Tsantzali
Overview
Explore the profile of Ioanna Tsantzali including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsantzali I, Athanasaki A, Boufidou F, Constantinides V, Stefanou M, Moschovos C, et al.
Biomedicines
. 2025 Jan;
12(12.
PMID: 39767810
: Alzheimer's disease (AD) may present with pure (typical or atypical) and mixed phenotypes, sometimes causing difficulties in (differential) diagnosis. In order to achieve a diagnostic accuracy as high as...
2.
Theodorou A, Tsantzali I, Stefanou M, Sacco S, Katsanos A, Shoamanesh A, et al.
Eur Stroke J
. 2024 Jun;
:23969873241260538.
PMID: 38869035
Introduction: There are limited data regarding cerebrospinal fluid (CSF) and plasma biomarkers among patients with Cerebral Amyloid Angiopathy (CAA). We sought to investigate the levels of four biomarkers [β-amyloids (Aβ42...
3.
Androutsakos T, Tsantzali I, Karagiannakis D, Flevari P, Iakovou D, Pouliakis A, et al.
Viruses
. 2024 Apr;
16(4).
PMID: 38675865
Chronic hepatitis C virus (HCV) infection is characterized by a variety of extra-hepatic manifestations; peripheral neuropathy (PN) is one of the most common, especially when mixed cryoglobulinemia (MCG) is present....
4.
Voumvourakis K, Sideri E, Papadimitropoulos G, Tsantzali I, Hewlett P, Kitsos D, et al.
Biomedicines
. 2023 Aug;
11(8).
PMID: 37626589
The process of memory entails the activation of numerous neural networks and biochemical pathways throughout the brain. The phenomenon of memory decline in relation to aging has been the subject...
5.
Anagnostou D, Sfakianaki G, Melachroinou K, Soutos M, Constantinides V, Vaikath N, et al.
Diagnostics (Basel)
. 2023 Jul;
13(13).
PMID: 37443586
Even though it is currently well-established that α-synuclein aggregation is closely associated with the pathological events in Parkinson's disease (PD) and several other neurodegenerative disorders, collectively called synucleinopathies, the mechanistic...
6.
Paraskevas G, Constantinides V, Boufidou F, Tsantzali I, Pyrgelis E, Liakakis G, et al.
Diagnostics (Basel)
. 2022 Dec;
12(12).
PMID: 36553018
Besides the typical amnestic presentation, neuropathological studies indicate that Alzheimer's disease (AD) may present with atypical clinical pictures. The relative frequencies of typical and atypical or mixed presentations within the...
7.
Breza M, Kotsali-Peteinelli V, Tsantzali I, Mavromatos A, Strataki E, Bonakis A, et al.
Cereb Circ Cogn Behav
. 2022 Nov;
2:100009.
PMID: 36324724
•Hydrocephalus is rarely reported in patients with diffuse glioma.•We describe a patient with a low-grade glioma presenting a complex phenotype initially masquerading as hydrocephalus of unknown etiology.•The exact pathophysiological mechanism...
8.
Theodorou A, Tsantzali I, Kapaki E, Constantinides V, Voumvourakis K, Tsivgoulis G, et al.
Cereb Circ Cogn Behav
. 2022 Nov;
2:100010.
PMID: 36324707
Sporadic cerebral amyloid angiopathy (CAA) is a cerebral small vessel disease, characterized by the deposition of β-amyloid within the cortical and leptomeningeal blood vessel walls. It has attracted interest concerning...
9.
Tsantzali I, Foska A, Sideri E, Routsi E, Tsomaka E, Kitsos D, et al.
Biomedicines
. 2022 Aug;
10(8).
PMID: 36009425
Cerebrospinal fluid (CSF) biomarkers remain the gold standard for fluid-biomarker-based diagnosis of Alzheimer's disease (AD) during life. Plasma biomarkers avoid lumbar puncture and allow repeated sampling. Changes of plasma phospho-tau-181...
10.
Tzartos J, Boufidou F, Stergiou C, Kuhle J, Willemse E, Palaiodimou L, et al.
Biomolecules
. 2022 Aug;
12(8).
PMID: 36008993
Blood phospho-tau181 may offer a useful biomarker for Alzheimer's disease. However, the use of either serum or plasma phospho-tau181 and their diagnostic value are currently under intense investigation. In a...